baber/WOPTO huggingface dataset:
Patent FI-924699-A0 (FI)
Inventor: SEPPAELAE JUKKA
IPC: C08G63/06
Filed: 1992-10-16
Abstract: The present invention relates to the production of lactic acid-based polyurethanes. In the first phase of the production, monomeric lactic acid is polymerized into an oligomer having a molecular weight of about 500 to 10,000. Next, the oligomer thus obtained is copolymerized with an isocyanate which reacts with the free hydroxyl and carboxyl groups of the oligomer to produce a high molecular weight polyurethane. The lactic acid used need not be absolutely pure. Various biodegradable end products can be obtained suitable for use as material for disposable packages, agricultural film or planting pots, or a coating for fertilizer granules.
Patent FI-925875-A0 (FI)
Inventor: DESAI RANJIT CHIMANLAL
IPC: C07F9/6547
Filed: 1992-12-23
Abstract: Novel 4-R1-R2-R3-2-saccharinylmethyl, 4-R4-4-R5-6-R6-4,5,6,7-tetrahydro-2-saccharinylmethyl and 4,7-C-4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates of formulas I, II and IIA respectively <CHEM> are useful in the treatment of degenerative diseases, and compositions containing them, methods for using them to treat degenerative diseases, and processes for their preparation by reaction of the corresponding 2-halomethylsaccharins with a phosphate, phosphonate or phosphinic acidderivative.
Patent FI-933894-A0 (FI)
Inventor: HAEMAELAEINEN JARI
IPC: H04W88/16
Filed: 1993-09-06
Abstract: A communications system comprises a mobile communication means and a fixed communication means. The mobile communication means is configured to store a parameter of the fixed communication means for setting up a virtual data communication channel with it. The fixed communication means is configured to store a parameter of the mobile communication means for setting up a virtual data communication channel with it. At least one of said mobile communication means and said fixed communication means is configured to expedite establishment of a real data communication channel through application of a previously stored parameter of the other communication means.
Patent FI-940806-A0 (FI)
Inventor: HIMMELSBACH FRANK
IPC: A61P43/00
Filed: 1994-02-21
Abstract: Azobicyclic compounds which are substituted by a cyclic urea radical, or their derivatives, such as e.g. the compound <IMAGE> have cell aggregation-inhibiting actions and can be employed for the preparation of e.g. anti-inflammatory or anti-tumour and anti-thrombotic medicaments.
Patent FI-955316-A0 (FI)
Inventor: HESSE ROBERT HENRY
IPC: A61K31/59
Filed: 1995-11-06
Abstract: PCT No. PCT/GB94/00975 Sec. 371 Date Jan. 5, 1996 Sec. 102(e) Date Jan. 5, 1996 PCT Filed May 6, 1994 PCT Pub. No. WO94/26707 PCT Pub. Date Nov. 24, 1994The invention relates to novel 1 alpha -hydroxy vitamin D derivatives and their 20-epi analogues, comprising compounds of general formula (I)    <IMAGE>  (I)  where R1 and R2, which may be the same or different, each represents a hydrogen atom or an aliphatic, cycloaliphatic, araliphatic or aryl group or together with the nitrogen atom to which they are attached form a heterocyclic group; R3 represents a methyl group having  alpha - or  beta -configuration; X represents a valence bond or a C1-2alkylene group; Y represents -O-, -S-, -CH2- or -NR- where R is a hydrogen atom or an organic group; Z represents a valence bond or a C1-3alkylene group; and A= represents a cyclohexylidene moiety characteristic of the A-ring of a 1 alpha -hydroxylated vitamin D or analogue thereof, with the proviso that when -X-Y-Z- together represent an alkylene group containing up to 4 carbon atoms A= does not carry an exocyclic methylene group at the 10-position. Active compounds of the invention exhibit cell modulating activity while exhibiting a substantial lack of calcemic effect.\!
Patent FI-971857-A0 (FI)
Inventor: ELLIOTT ROBERT BARTLETT
IPC: C12Q1/6876
Filed: 1997-04-30
Abstract: The invention is based on the discovery that certain variants of beta-casein may induce Type-1 diabetes in susceptible individuals while other variants do not. The invention consists of the selection of non-diabetogenic milk producing cows and recovering and processing their milk and milk products. Another aspect of the invention is selectively breeding cows which produce the non-diabetogenic milk.
Patent AP-9901641-A0 (AP)
Title: Anti-parasitic action of N,N-Diethyl-m-toluamide (DEET) and formulations that prolong its activity in the skin.
Inventor: SALAFSKY BERNARD
IPC: A61P33/00
Filed: 1998-02-10
Abstract: Novel formulations of deet are provided which comprise liposomes and other carriers. Methods and materials for preventingschistomiasis and other parasitic and microbial diseases are also provided. Also provided are improved materials and methods for repelling biting insects.
Patent IL-65035-A0 (IL)
Title: Benzamido derivatives
IPC: A61K31/60
Filed: 1982-02-17
Abstract: Novel therapeutically active compounds of the formula   <IMAGE> I wherein R1 and R2 are the same or different and each represents a hydrogen atom, a halogen atom, a cyano group, a lower alkyl group or an acyl group, R3 is a lower alkyl group; an alkenyl group; or a benzyl group optionally substituted with fluorine, chlorine, bromine, trifluoromethyl, lower alkyl or lower alkoxy, A1 and A2 are the same or different and each represents a hydrogen atom, a lower alkyl group, an acyl group, an alkoxycarbonyl group or a dialkylcarbamyl group, provided that when A1 and A2 are the same lower alkyl group and R3 is ethyl, R1 or R2 or both are selected among cyano, lower alkyl and acyl; or a physiologically acceptable salt or optical isomers thereof, methods for their preparation, pharmaceutical preparations containing the compounds and methods for their therapeutical use.
Patent IL-70400-A0 (IL)
Title: Manufacture of chiral azetidinones
IPC: C07D407/04
Filed: 1983-12-07
Abstract: Manufacture of chiral azetidinones of the general formula 
<CHEM>
 wherein R is an amino protecting group and M +/ &cir& is a cation, starting from L-ascorbic acid. Several alternatives lead, over a number of novel intermediates, to a novel intermediate of the formula 
<CHEM>
 wherein R and M +/ &cir& are as above and R<9>O- is a leaving group, which is treated with an alkali metal carbonate or bicarbonate, whereupon the compound of formula II is recovered from the reaction mixture. 
<??>The compounds of formula II are useful for preparing the new sulfazecin related antibiotic compound of the formula 
<CHEM>
 
<??>This new antibiotic is similar in activity to the antibiotic azthreonam and useful in treating infectious diseases caused by gram negative microorganisms, particularly P. aeruginosa.
Patent IL-70506-A0 (IL)
Title: Optically active phenoxypropionic acid derivatives,their preparation and their use as herbicides
IPC: A01N41/10
Filed: 1983-12-21
Abstract: New dextrorotatory enantiomers of phenoxy propionic acid derivatives of the formula    <IMAGE>  (I)  in which R1 represents a radical of the formula   <IMAGE>  wherein X1 represents hydrogen or halogen, X2 represents halogen or trifluoromethyl, X3 represents halogen or trifluoromethyl, X4 represents hydrogen or halogen and X5 represents hydrogen or halogen, Y represents oxygen or the radical SOm, wherein m represents 0, 1 or 2, R2 represents hydrogen or methyl, n represents 1 or 2 and R3 and R4 independently of one another represent hydrogen, halogen, alkyl with 1 to 4 carbon atoms, alkoxy with 1 to 4 carbon atoms, alkylthio with 1 to 4 carbon atoms, nitro, cyano or alkoxycarbonyl with 1 to 4 carbon atoms in the alkoxy group, and their use as herbicides.
Patent IL-78769-A0 (IL)
Title: Monoclonal antibodies for human non-small cell lung carcinomas
IPC: G01N33/577
Filed: 1986-05-13
Abstract: The present invention is concerned with two novel monoclonal antibodies which define carbohydrate antigens associated with human non-small cell lung carcinomas («NSCLC») and certain other human carcinomas. The antibodies bind to normal human cells to a much lesser degree than to tumor cells. The antibodies find use in diagnostic methods such as the detection of malignant cells associated with NSCLC and in therapeutic methods. The invention also comprises a method for determining the presence of a malignant condition in the lung of a subject. The method involves examining tissue from the subject for the presence of antigens which are Le<sup>x</sup> or Le<sup>Y</sup> antigen or which have the characteristics of Le<sup>Y</sup> and Le<sup>x</sup>.
Patent IL-79618-A0 (IL)
Title: Process and apparatus for mass production of an insect entomophage
IPC: A01K67/00
Filed: 1986-08-04
Abstract: The invention relates to a method for the mass production of an entomophagous insect such as Trichogramma maidis insect from a substitution host such as the egg of the meal moth Ephestia kuehniella, as well as a device for implementation of this method and the application of the method to the biological fight against maize crop ravagers.
Patent IL-87353-A0 (IL)
Title: Propellant charge for cannons and a method of producing such a charge
IPC: F42B5/16
Filed: 1988-08-04
Abstract: The disclosure relates to a propellant charge for cannons comprising bundles (11) of tightly held tubular propellant sticks which are provided with connections between the propellant sticks' outer surfaces and their combustion channels, these connections consisting of either longitudinal slits (4) or of uniformly spaced, weakened points in the form of perforations, slits, open notches or bored holes which extend from the outer surfaces of the propellant sticks to the combustions channels, the bundles (11) being surrounded by disorientated powder flakes, powder grains or short powder rods or tubes (9), these filling the remaining portion of the combustion space (7). The disclosure also relates to a method of producing such a charge.
Patent IL-94439-A0 (IL)
Title: Intravascular drug delivery dilation catheter
IPC: A61F2/06
Filed: 1990-05-18
Abstract: An intravascular catheter (10) designed to apply a liquid medicament or other substance to a stenotic lesion as the blood vessel is undergoing dilatation to facilitate the restoration and long-term maintenance of patency to the blood vessel. It comprises three concentrically arranged flexible plastic tubes (12, 14, 16) and a pair of concentrically arranged expander members (22, 30) located at the distal end of the tubes. The space between the outer wall of the inner tube (16) and the inner wall of the intermediate tube (14) is in fluid communication with the interior of the first expander member (22) while the space between the outer wall of the intermediate tube (14) and the inner wall of the outer tube (12) is in fluid communication with the interior of the second expander member (30). A plurality of minute holes (28) are formed through the second expander member (30) such that when the liquid medicament is introduced into the lumen (32) of the outer tube (12) while an inflation fluid is introduced into the lumen (34) of the intermediate tube (14), both expander members (22, 30) inflate with the drug or other substance being ejected out through the tiny pores (28) of the outermost expander member (22) while continued inflation of the inner expander member (30) provides the necessary pressure for dilatation of the lesion.
Patent IL-99133-A0 (IL)
Title: Laminated film with a starchy matrix and low permeability and methods for its production
IPC: B32B27/18
Filed: 1991-08-08
Abstract: A laminated film including at least one first layer of a polymeric material which has a starchy matrix and is insoluble in water or at most expands in water, constituted by destructured starch and an olefinic copolymer and a second layer of a hydrophobic material adhering to the first. Applications are for the packaging of food products and for colostomy containers, for which a very effective barrier against gases and vapours is needed.
Patent AU-PQ065599-A0 (AU)
Title: Progressive lens
IPC: G02C7/02
Filed: 1999-05-31
Abstract: A series of progressive opthalmatic lens elements, each lens element including a lens surface having an upper viewing zone having a surface power to achieve a refracting power corresponding to distance vision; a lower viewing zone having a greater surface power than the upper viewing zone to achieve a refracting power corresponding to near vision; a corridor of relatively low surface astigmatism connecting the upper and lower zones, said corridor having a surface power varying from that of the upper viewing zone to that of the lower viewing zone; the progressive opthalmatic lens series including a first set of lens elements having a base curve(s) suitable for use in providing a range of distance prescriptions for a first category of patient; and a second set of lens elements having a base curve(s) suitable for use in providing a range of distance prescriptions for a second category of patient; each lens element within a set differing in prescribed addition power and including a progressive design, in at least one of the upper and lower viewing zones, depending upon the addition power of the lens element; the lens elements in the first set differing substantively in progressive design from the corresponding lens elements in the second set due to the differences in base curve(s).
Patent FI-20070964-A0 (FI)
Inventor: MAEKI-ONTTO PETRI
IPC: H01F/
Filed: 2007-12-11
Abstract: The object of the invention is a permanent magnet module (2) comprising at least two permanent magnets (6) with the first magnetic pole on the first plane surface (20) and the second magnetic pole on the second plane surface, and a cover (3) at least partially enveloping the permanent magnets (6). According to the invention the cover (3) of the module is magnetically conductive and comprises a top surface, substantially covering the first plane surface (20) of the permanent magnet, and a bottom surface (3), substantially covering the second plane surface of the permanent magnet. The cover (3) is at least partially open at the side surfaces (24) of the permanent magnet (6). Another object of the invention is a rotor for an electrical machine, the rotor having permanent magnets fitted into a corresponding module.
Patent IL-112807-A0 (IL)
Title: Method and apparatus for clearing excess beverage containers from a packaging machine
IPC: B65B35/30
Filed: 1995-02-27
Abstract: A method is disclosed for clearing excess trailing beverage containers from the lanes defined between guide rails in a beverage container packaging machine. The method includes providing the guide rails with compressed air nozzles that are positioned and oriented to direct compressed air along the lanes defined between the guide rails in the desired direction of movement of beverage containers along the lanes. An apparatus that includes an improved guide rail configured to achieve the method of the invention is also provided.
Patent IL-113899-A0 (IL)
Title: Fungicidal compositions and their uses
IPC: A01P3/00
Filed: 1995-05-29
Abstract: PCT No. PCT/EP95/02027 Sec. 371 Date Dec. 10, 1996 Sec. 102(e) Date Dec. 10, 1996 PCT Filed May 27, 1995 PCT Pub. No. WO95/34206 PCT Pub. Date Dec. 21, 1995Fungicidal mixtures comprising a) the oxime ether carboxylic ester of the formula I    <IMAGE>noacetyl)-3-ethylurea (II)H3CCH2-NHCONH-C (CN)=NOCH3IIin a synergistically effective amount.
Patent IL-124728-A0 (IL)
Title: Diagnosis and treatment of aur-1 and/or aur-2 related disorders
IPC: A61K38/00
Filed: 1996-11-25
Abstract: The present invention relates to AUR-1 and/or AUR-2 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for AUR-1 and/or AUR-2 related diseases or conditions characterized by an abnormal interaction between an AUR-1 and/or AUR-2 polypeptide and an AUR-1 and/or AUR-2 binding partner.
Patent IL-134454-A0 (IL)
Title: Process for the production of 2,3,5- trimethylhydroquinone diesters
IPC: C07B61/00
Filed: 2000-02-09
Abstract: Preparation of 2,3,5-trimethylhydroquinone diester derivatives (I) comprises treatment of 2,6,6-trimethyl-cyclohex-2-en-1,4-dione (ketoisophorone) (II) with an acylating agent in the presence of a catalytic amount of a protic acid (i.e. an ortho-boric acid, a boric acid anhydride, a boric acid triester, a hydroxycarboxylic acid or a di- or tri-carboxylic acid optionally containing hydroxy groups). Preparation of trimethylhydroquinone diester derivatives of formula (I) comprises treatment of 2,6,6-trimethyl-cyclohex-2-en-1,4-dione (ketoisophorone) of formula (II) with an acylating agent in the presence of a catalytic amount of a protic acid (i.e. an ortho-boric acid, a boric acid anhydride, a boric acid triester, a hydroxycarboxylic acid or a di- or tri-carboxylic acid optionally containing hydroxy groups.  N.B. R and R1 are not defined in the main claim, but in a dependent claim are defined as:  R, R1 = optionally substituted 1-20 (especially 2-4)C aliphatic, alicyclic residue or aryl (especially phenyl).
Patent IL-138608-A0 (IL)
Title: Antibody variants and fragments thereof
IPC: C12P21/08
Filed: 1999-03-31
Abstract: A variant of a polypetide comprising a human IgG Fc region is described, which variant comprises an amino acid substitution at one or more of amino acid positions 270, 322, 326, 327, 329, 331, 333 or 334 of the human IgG Fc region. Such variants display altered effector function. For example, C1q binding and/or complement dependent cytotoxicity (CDC) activity may be altered in the variant polypeptide. The application also discloses a variant of a parent polypeptide comprising a human IgG Fc region, which variant has a better binding affinity for human C1q than the parent polypeptide.
Patent IL-141608-A0 (IL)
Title: Pattern carrier for use in transfer pattern printing and the use of a non-crystalline saccharide syrup in a dispersion for coating a paper web so as to obtain such a pattern carrier
IPC: B44C1/175
Filed: 1999-08-16
Abstract: A pattern carrier for use in transfer pattern printing of textiles comprises paper with an air permeability (Bendtsen-porosity) of more than 500 ml/min and a water absorption corresponding to a Cobb-number of at least 50, said paper being coated with an aqueous dispersion of carboxymethylcellulose containing a non-crystallizing saccharide syrup, preferably in an amount of approximately 30 g of dispersion per m<2>, whereafter one or more color pattern are printed on said paper, each color pattern comprising a water-soluble or dispersible dye admixed an easily soluble thickening carrier with a temporary binding effect, preferably in form of carboxymethylcellulose. The use of a saccharide syrup, preferably a sorbitol syrup, for the coating renders it possible to use standard-absorbing crude paper as the basis of the pattern carrier, which provides obvious financial and production-related advantages.
Patent IL-143164-A0 (IL)
Title: Pressure sensor
IPC: H01L29/84
Filed: 1999-11-17
Abstract: The invention relates to a pressure sensor consisting of a chip (11) which is mounted on a support wall (10) and which is provided with a resistance unit consisting of strip conductors and being arranged at the lower side (13) of a substrate (12). Said lower side faces the support wall (10). The resistance unit is located on a thin membrane (18). A recess (19) is located behind said membrane. The chip (11) is fixed on the support wall (10) by means of an elastic intermediate layer (26). The electrical components of the chip are protectively arranged between the substrate (12) and the support wall (10). The invention provides for an extremely flat sensor unit without additional sensor housing. Said sensor unit can even be used for measuring pressures in electrically conductive mediums.
Patent IL-145759-A0 (IL)
Title: Amine derivatives and pharmaceutical compositions containing the same
IPC: C07D417/12
Filed: 2000-04-06
Abstract: An amine derivative compound of the formula (I): <CHEM>     wherein R1 represents an optionally substituted carbamoyl group, etc., R2 represents a hydrogen atom, etc., R3 represents a C1-C10 alkyl group etc., W1, W2 and W3 are the same or different and each represent a single bond or a C1-C8 alkylene group, X, Y and Q represent a sulfur atom, etc., Z represents a =CH- group, etc., Ar represents a benzene ring, etc. and L represents a hydrogen atom, etc.   or a pharmacologically acceptable salt thereof is useful as a therapeutic and/or preventing agent for diabetes, hyperlipemia, arteriosclerosis, cancer, etc.
Patent IL-149543-A0 (IL)
Title: Method and apparatus for real time insertion of images into video
IPC: H04N5/272
Filed: 2000-11-07
Abstract: A method for inserting a target image into images of an image stream of a real site taken by a camera (108), the method comprising: receiving a stream of original images taken by a camera (108) of a real, three-dimensional site; placing at least one target image into a three-dimensional model of the site on at least one target area (502, 504); for each original image (400) in the image stream, rendering the three-dimensional model using data on a position and pointing direction of the camera (108) in the real site to generate a mask (900) and a rendered image containing said at least one target image (604); determining a background area (400a) in the original image (400) separate from the at least one target area (502, 504) using the mask (900); and combining the background area (400a) of the original image (400), and the at least one target image (604) into an output image (400e).
Patent IL-151237-A0 (IL)
Title: Packaging for a plaster containing active ingredients
IPC: A61J3/00
Filed: 2001-02-10
Abstract: A packing material is in the form of packaging laminate for packing transdermal therapeutic systems. The packing material contains at least a sealable layer and a barrier layer, and the sealable layer is provided with a continuous abhesive layer. The sealable layer can be provided with a silicone film or a silicone layer as the abhesive layer. The abhesive layer can have a thickness of less than 10 mum, preferably less than 5 mum.
Patent IL-151560-A0 (IL)
Title: Lipid nanocapsules, preparation method and use as medicine
IPC: A61K9/51
Filed: 2001-03-02
Abstract: The invention concerns nanocapsules, in particular with an average size less than 50 nm, consisting of an essentially lipid core liquid or semiliquid at room temperature, coated with an essentially lipid film solid at room temperature having a thickness of 2-10 nm. The invention also concerns a method for preparing same which consists in producing a reverse phase of an aqueous emulsion brought about by several temperature raising and lowering cycles. Said lipid nanocapsules are particularly designed for producing a medicine.
Patent IL-155354-A0 (IL)
Title: Systems and methods for robust real-time measurement of network performance
IPC: H04L12/56
Filed: 2001-10-04
Abstract: Methods and apparatuses for obtaining delay, jitter, and loss statistics of a path between server and an end user coupled via an internetwork are described. The server may comprise a web server in communication with the end user via the Internet. Statistics are obtained by analyzing the details of a TCP connection underlying an HTML transaction. Robust measurements of jitter, delay, and loss are ensured by maximizing traffic between the web server and the surfer in order to generate a robust sample of TCP connections. Content may be updated with one or more html link(s). This existing content may reside on a highly trafficked portal, such as a web portal, and may be encoded in a markup language, such as Hyper Text Markup Language (HTML). The Uniform Resource Locators (URLs) corresponding to the one or more links resolve to the server from which the statistics are to be measured. The actual content supplied by the server may be minimized, in order to preserve bandwidth.